KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Elanco Animal Health (ELAN) Current Assets: 2017-2025

Historic Current Assets for Elanco Animal Health (ELAN) over the last 7 years, with Sep 2025 value amounting to $3.5 billion.

  • Elanco Animal Health's Current Assets rose 3.77% to $3.5 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $3.5 billion, marking a year-over-year increase of 3.77%. This contributed to the annual value of $3.2 billion for FY2024, which is 5.64% down from last year.
  • Per Elanco Animal Health's latest filing, its Current Assets stood at $3.5 billion for Q3 2025, which was down 3.35% from $3.6 billion recorded in Q2 2025.
  • Elanco Animal Health's 5-year Current Assets high stood at $4.0 billion for Q1 2024, and its period low was $3.2 billion during Q3 2022.
  • Its 3-year average for Current Assets is $3.6 billion, with a median of $3.5 billion in 2023.
  • Its Current Assets has fluctuated over the past 5 years, first grew by 14.15% in 2024, then dropped by 15.06% in 2025.
  • Elanco Animal Health's Current Assets (Quarterly) stood at $3.3 billion in 2021, then rose by 0.15% to $3.3 billion in 2022, then increased by 3.90% to $3.4 billion in 2023, then decreased by 5.64% to $3.2 billion in 2024, then rose by 3.77% to $3.5 billion in 2025.
  • Its Current Assets stands at $3.5 billion for Q3 2025, versus $3.6 billion for Q2 2025 and $3.4 billion for Q1 2025.